Hormone Dynamics and Bone Mineral Density in Anorexia Nervosa v. Hypothalamic Amenorrhea

Completed

• Conditions: Anorexia Nervosa; Hypothalamic Amenorrhea; Obesity

• Registration Number: NCT00556036
• Lead Sponsor: Massachusetts General Hospital

Brief Summary

The purpose of this study is to determine whether the hormone dynamics in women with anorexia nervosa and hypothalamic amenorrhea is related to bone loss in those populations.

Detailed Description

Not available

Study Timeline

• Study Start: 2006-03
• Study First Submitted: 2007-11-07
• Study First Submitted QC: 2007-11-07
• Study First Posted: 2007-11-09
• Primary Completion: 2009-03
• Study Completion: 2009-03
• Status Verified: 2020-08
• Last Update Submitted: 2020-08-31
• Last Update Posted: 2020-09-02

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 61

Inclusion Criteria

• Amenorrhea for at least three months (unless participating as healthy control)
• Normal TSH or free thyroxine (free T4).

Exclusion Criteria

• A condition known to affect bone metabolism, including Cushing's syndrome or renal failure, with the exception of bone fracture.
• Any medication known to affect bone metabolism within 3 months of the study, including estrogen and progestins. Patients receiving depot medroxyprogesterone (Depo-Provera) will be excluded from participating for 6 months after their last injection.
• Pregnant and/or breastfeeding.
• Diabetes mellitus.
• Active substance abuse, including alcohol.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Trial Locations

Locations (1)

Massachusetts General Hospital; 🇺🇸 Boston, Massachusetts, United States